[
    [
        {
            "time": "",
            "original_text": "贝达药业（300558.SZ）：股东济和创投解除质押190万股",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "济和创投",
                    "解除质押",
                    "190万股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贝达药业（300558.SZ）：股东济和创投解除质押190万股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "贝达药业今日大宗交易成交10万股，成交价129.0元折价0.39%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "大宗交易",
                    "10万股",
                    "129.0元",
                    "折价0.39%"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝达药业今日大宗交易成交10万股，成交价129.0元折价0.39%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "绩优基金何以表现亮眼，聪明钱与好公司互相成就",
            "features": {
                "keywords": [
                    "绩优基金",
                    "表现亮眼",
                    "聪明钱",
                    "好公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "绩优基金何以表现亮眼，聪明钱与好公司互相成就",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "上市公司创新药8月报告：第一梯队在研品种近百个，抗肿瘤药占半壁江山",
            "features": {
                "keywords": [
                    "上市公司",
                    "创新药",
                    "8月报告",
                    "第一梯队",
                    "在研品种",
                    "抗肿瘤药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市公司创新药8月报告：第一梯队在研品种近百个，抗肿瘤药占半壁江山",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]